| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CLINBIOCHEM.2011.04.004 |
| P698 | PubMed publication ID | 21549691 |
| P50 | author | Lars M Rasmussen | Q46237462 |
| P2093 | author name string | Yu Cao | |
| Morten A Karsdal | |||
| Efstathios Vassiliadis | |||
| Qinlong Zheng | |||
| Thomas C Register | |||
| Jianxia Wang | |||
| Rui Xing | |||
| Natasha Barascuk | |||
| Lise Larsen | |||
| Jean-Paul Vilaine | |||
| Nicole Villeneuve | |||
| Massimo Sabatini | |||
| Christine Crespo | |||
| Isabelle Lapret | |||
| P433 | issue | 10-11 | |
| P921 | main subject | ELISEA | Q332126 |
| biomarker | Q864574 | ||
| P304 | page(s) | 900-906 | |
| P577 | publication date | 2011-04-30 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen--A novel biomarker of atherosclerotic plaque remodeling | |
| P478 | volume | 44 |
| Q90668912 | 1,25(OH)2D3 Strengthens the Vasculogenesis of Multipotent Mesenchymal Stromal Cells from Rat Bone Marrow by Regulating the PI3K/AKT Pathway |
| Q35460015 | Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies |
| Q36576517 | Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development |
| Q36367463 | Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker. |
| Q90402187 | Effects of a natural multi-component compound formulation on the growth, morphology and extracellular matrix production of human adult dermal fibroblasts |
| Q36672445 | Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure |
| Q36402230 | Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist. |
| Q35440249 | Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice |
| Q92377224 | Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis |
| Q35622533 | Novel insights into the function and dynamics of extracellular matrix in liver fibrosis |
| Q34515203 | Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model |
| Q64076879 | Promoting therapeutic angiogenesis of focal cerebral ischemia using thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) in a rat model |
| Q33678336 | Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis |
Search more.